• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alchemia Ltd/Australia

+ Add to Watchlist

QA9:GR

0.017 EUR 0.0000.00%

As of 03:06:48 ET on 12/19/2014.

Snapshot for Alchemia Ltd/Australia (QA9)

Open: 0.017 Day's Range: 0.017 - 0.017 Volume: 0
Previous Close: 0.017 52wk Range: 0.015 - 0.454 1-Yr Rtn: -94.60%

Stock Chart for QA9

No chart data available.
  • QA9:GR 0.017
  • 1D
  • 1M
  • 1Y
0.017
Interactive QA9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QA9

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 2.5597
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) 0.0100
Est. PEG Ratio -
Market Cap (M EUR) 5.52
Shares Outstanding (M) 324.70
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QA9

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for QA9

Alchemia Limited is a biotechnology company that develops carbohydrate based molecules for pharmaceutical applications. The Company's products are used in drug development in the field of antibiotics and anti-cancer drugs.

Tracie RamsdaleExec Dir/Co-FounderJennifer Pilcher "Jenni"Chief Financial Officer
Tracey Jean BrownVP:Oncology/Chief Scientific OfcrStephen Anthony DenaroSecretary
More Company Profile & Key Executives for QA9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil